SOD1 and amyotrophic lateral sclerosis: This would not be surprising as multiple studies designed to reduce mutSOD1 in the CNS revealed that silencing in SOD1 gene expression only was able to significantly delay ALS onset and/or extend lifespan when the treatment was started during early developmental, strongly declining efficacy in maturing mice (Zundert and Brown 2017).